pubmed-article:17192960 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:17192960 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
pubmed-article:17192960 | lifeskim:mentions | umls-concept:C0036186 | lld:lifeskim |
pubmed-article:17192960 | lifeskim:mentions | umls-concept:C1522318 | lld:lifeskim |
pubmed-article:17192960 | lifeskim:mentions | umls-concept:C0009566 | lld:lifeskim |
pubmed-article:17192960 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
pubmed-article:17192960 | lifeskim:mentions | umls-concept:C1948041 | lld:lifeskim |
pubmed-article:17192960 | lifeskim:mentions | umls-concept:C0247025 | lld:lifeskim |
pubmed-article:17192960 | lifeskim:mentions | umls-concept:C0475224 | lld:lifeskim |
pubmed-article:17192960 | lifeskim:mentions | umls-concept:C0087086 | lld:lifeskim |
pubmed-article:17192960 | lifeskim:mentions | umls-concept:C0681842 | lld:lifeskim |
pubmed-article:17192960 | lifeskim:mentions | umls-concept:C0522523 | lld:lifeskim |
pubmed-article:17192960 | lifeskim:mentions | umls-concept:C1527362 | lld:lifeskim |
pubmed-article:17192960 | lifeskim:mentions | umls-concept:C1521840 | lld:lifeskim |
pubmed-article:17192960 | lifeskim:mentions | umls-concept:C2348205 | lld:lifeskim |
pubmed-article:17192960 | lifeskim:mentions | umls-concept:C0592046 | lld:lifeskim |
pubmed-article:17192960 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:17192960 | pubmed:dateCreated | 2007-4-3 | lld:pubmed |
pubmed-article:17192960 | pubmed:abstractText | Saphenous vein graft (SVG) percutaneous coronary intervention (PCI) carries a high risk of ischemic complications. However, there are scant recent data to identify which SVG lesions carry particularly high risk in recent years. We studied demographic and angiographic factors associated with ischemic complications after SVG PCI without distal protection in the TARGET (do tirofiban and reopro give similar efficacy trial?) study. | lld:pubmed |
pubmed-article:17192960 | pubmed:language | eng | lld:pubmed |
pubmed-article:17192960 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17192960 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:17192960 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17192960 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17192960 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17192960 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17192960 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17192960 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17192960 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17192960 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:17192960 | pubmed:month | Apr | lld:pubmed |
pubmed-article:17192960 | pubmed:issn | 1522-1946 | lld:pubmed |
pubmed-article:17192960 | pubmed:author | pubmed-author:BergerPeterP | lld:pubmed |
pubmed-article:17192960 | pubmed:author | pubmed-author:BlankenshipJa... | lld:pubmed |
pubmed-article:17192960 | pubmed:author | pubmed-author:Fenalti... | lld:pubmed |
pubmed-article:17192960 | pubmed:author | pubmed-author:HerrmannHowar... | lld:pubmed |
pubmed-article:17192960 | pubmed:author | pubmed-author:MoliternoDavi... | lld:pubmed |
pubmed-article:17192960 | pubmed:author | pubmed-author:McClureRickR | lld:pubmed |
pubmed-article:17192960 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:17192960 | pubmed:day | 1 | lld:pubmed |
pubmed-article:17192960 | pubmed:volume | 69 | lld:pubmed |
pubmed-article:17192960 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:17192960 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:17192960 | pubmed:pagination | 623-9 | lld:pubmed |
pubmed-article:17192960 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
pubmed-article:17192960 | pubmed:meshHeading | pubmed-meshheading:17192960... | lld:pubmed |
pubmed-article:17192960 | pubmed:meshHeading | pubmed-meshheading:17192960... | lld:pubmed |
pubmed-article:17192960 | pubmed:meshHeading | pubmed-meshheading:17192960... | lld:pubmed |
pubmed-article:17192960 | pubmed:meshHeading | pubmed-meshheading:17192960... | lld:pubmed |
pubmed-article:17192960 | pubmed:meshHeading | pubmed-meshheading:17192960... | lld:pubmed |
pubmed-article:17192960 | pubmed:meshHeading | pubmed-meshheading:17192960... | lld:pubmed |
pubmed-article:17192960 | pubmed:meshHeading | pubmed-meshheading:17192960... | lld:pubmed |
pubmed-article:17192960 | pubmed:meshHeading | pubmed-meshheading:17192960... | lld:pubmed |
pubmed-article:17192960 | pubmed:meshHeading | pubmed-meshheading:17192960... | lld:pubmed |
pubmed-article:17192960 | pubmed:meshHeading | pubmed-meshheading:17192960... | lld:pubmed |
pubmed-article:17192960 | pubmed:meshHeading | pubmed-meshheading:17192960... | lld:pubmed |
pubmed-article:17192960 | pubmed:meshHeading | pubmed-meshheading:17192960... | lld:pubmed |
pubmed-article:17192960 | pubmed:meshHeading | pubmed-meshheading:17192960... | lld:pubmed |
pubmed-article:17192960 | pubmed:meshHeading | pubmed-meshheading:17192960... | lld:pubmed |
pubmed-article:17192960 | pubmed:meshHeading | pubmed-meshheading:17192960... | lld:pubmed |
pubmed-article:17192960 | pubmed:meshHeading | pubmed-meshheading:17192960... | lld:pubmed |
pubmed-article:17192960 | pubmed:meshHeading | pubmed-meshheading:17192960... | lld:pubmed |
pubmed-article:17192960 | pubmed:meshHeading | pubmed-meshheading:17192960... | lld:pubmed |
pubmed-article:17192960 | pubmed:meshHeading | pubmed-meshheading:17192960... | lld:pubmed |
pubmed-article:17192960 | pubmed:meshHeading | pubmed-meshheading:17192960... | lld:pubmed |
pubmed-article:17192960 | pubmed:meshHeading | pubmed-meshheading:17192960... | lld:pubmed |
pubmed-article:17192960 | pubmed:meshHeading | pubmed-meshheading:17192960... | lld:pubmed |
pubmed-article:17192960 | pubmed:meshHeading | pubmed-meshheading:17192960... | lld:pubmed |
pubmed-article:17192960 | pubmed:meshHeading | pubmed-meshheading:17192960... | lld:pubmed |
pubmed-article:17192960 | pubmed:meshHeading | pubmed-meshheading:17192960... | lld:pubmed |
pubmed-article:17192960 | pubmed:year | 2007 | lld:pubmed |
pubmed-article:17192960 | pubmed:articleTitle | Thrombus predicts ischemic complications during percutaneous coronary intervention in saphenous vein grafts: results from TARGET (do Tirofiban and ReoPro give similar efficacy trial?). | lld:pubmed |
pubmed-article:17192960 | pubmed:affiliation | Department of Cardiology, Geisinger Medical Center, Danville, Pennsylvania 17822, USA. arunk@geisinger.edu | lld:pubmed |
pubmed-article:17192960 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:17192960 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:17192960 | pubmed:publicationType | Multicenter Study | lld:pubmed |